{"id":"W4387807073","doi":"10.1016/j.annonc.2023.09.1014","title":"2365MO Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)-ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Seagen","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Internal medicine; Clinical endpoint; Cohort; Tolerability; Perioperative; Neoadjuvant therapy; Oncology; Gastroenterology; Cancer; Surgery; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005671491,0.0004616358,0.0008366621,0.0002442845,0.000288803,0.0012285,0.0003838774,0.0005881478,0.004628338],"category_scores_gemma":[0.0006431442,0.0003171872,0.001980211,0.0004460933,0.0002816402,0.0004574173,0.0004350017,0.001285653,0.0009912292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006580555,"about_ca_system_score_gemma":0.001017772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003125891,"about_ca_topic_score_gemma":0.008931347,"domain_scores_codex":[0.9996229,0.0001223406,0.00002700134,0.00009194599,0.00003953382,0.00009608273],"domain_scores_gemma":[0.9997473,0.00003058539,0.00007293083,0.00004309707,0.00001936753,0.00008661707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5933108,0.003852225,0.2739859,0.001422503,0.009810141,0.0004099736,0.0002278048,0.001839615,0.01258519,0.001046958,0.02593862,0.07557033],"study_design_scores_gemma":[0.148884,0.09462102,0.6763317,0.0008024696,0.01235666,0.0008418764,0.0005682863,0.002121013,0.004900816,0.001468567,0.05697664,0.0001268892],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694444,0.002909089,0.0005489906,0.0004609007,0.0002659376,0.0005226234,0.0185892,0.00006241117,0.00719649],"genre_scores_gemma":[0.9641253,0.00107558,0.0005045029,0.001299088,0.0001991738,0.0005383138,0.02604087,0.00004701486,0.006170141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004628338,"threshold_uncertainty_score":0.01548332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09810588048068886,"score_gpt":0.4205012147464612,"score_spread":0.3223953342657723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}